45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Stuart Spencer, MSc

Senior Statistician
AstraZeneca
Alderley Park
Macclesfield United Kingdom SK10 4TF

Papers:
132 - Focused Plenary Analysis of intermediate clinical endpoints from a Phase II trial of olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC)